<DOC>
	<DOCNO>NCT00488046</DOCNO>
	<brief_summary>Over past decade , avian influenza ( AI ) become major health concern . The development safe effective vaccine H5N1 infection important . The purpose study determine safety new AI vaccine healthy adult .</brief_summary>
	<brief_title>Single Group Study Safety Immune Response Bird Flu Virus Vaccine ( H5N1 ) Healthy Adults</brief_title>
	<detailed_description>According World Health Organization , current pandemic risk associate avian influenza H5N1 infection serious , increase number human infect . Currently , H5N1 influenza transmission occurs human expose direct contact infect poultry surface object contaminate infected poultry feces . A pandemic occur new influenza subtype emerge infects human , cause serious illness , spread easily among human . The development safe effective vaccine necessary , pandemic occur . The purpose study evaluate safety immunogenicity live , attenuate A1 virus vaccine , H5N1 ( 6-2 ) AA ca Recombinant ( A/Hong Kong/213/2003 x A/AnnArbor/6/60 ca ) . This study last approximately 16 week . Participation study include hospital stay isolation unit Johns Hopkins Bayview Medical Center . All participant receive two dos vaccine nasal spray form , study entry sometime 4 8 week initial vaccination . Participants admitted isolation unit 2 day prior vaccination . A targeted physical exam occur daily follow vaccination discharge . Participants discharge nasal wash negative . Vital sign measurement do least twice daily duration inpatient stay . A follow-up outpatient visit occur approximately 4 week follow vaccination . Blood urine collection occur select timepoints throughout study .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Good general health Available duration study Willing use acceptable form contraception duration study Clinically significant neurologic , heart , lung , liver , rheumatologic , autoimmune , kidney disease Behavioral cognitive impairment psychiatric disease , opinion investigator , may affect study participation Medical , work , family problem result alcohol illicit drug use within 12 month prior study entry Previously enrol H5N1 influenza vaccine trial study avian influenza vaccine Seropositive H5N1 influenza A virus ( serum hemagglutination inhibitor [ HI ] titer great 1:8 ) Illegal drug use dependency determine urine test History severe allergic reaction Allergy oseltamivir Asthma reactive airway disease within 2 year prior study entry History GuillainBarre syndrome HIV infect Hepatitis C virus infect Positive hepatitis B surface antigen ( HBsAg ) Known immunodeficiency syndrome Use corticosteroid immunosuppressive drug within 30 day prior vaccination . Participants use topical corticosteroid exclude . Live vaccine within 4 week prior study vaccination Killed vaccine within 2 week prior study vaccination Absence spleen Blood product within 6 month prior study vaccination Current smoker unwilling stop smoking duration study Have travel Southern Hemisphere Asia within 14 day prior study vaccination Have travel cruise ship within 14 day prior study vaccination Work poultry industry Other investigational vaccine drug within 30 day prior study vaccination Allergy egg egg product Purified protein derivative ( PPD ) positive ( positive tuberculosis [ TB ] test ) Have family member immunodeficiencyrelated condition Other condition , opinion investigator , may interfere study Pregnancy breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Bird Flu</keyword>
</DOC>